\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ flank\\ pain\\.\\ microhematuria\\,\\ with\\ creatinine\\ of\\ 2\\.0\\.\\ remaining\\ labs\\ normal\\.\ \(0\)\
\-\ treated\\ with\\ a\\ mixture\\ of\\ sodium\\ and\\ potassium\\ bicarbonate\\,\\ constant\\ hydration\\.\ \(0\)\
\-\ severe\\ bilateral\\ medullary\\ nephrocalcinosis\ \(0\)\
\-\ renal\\ tubular\\ acidosis\\,\\ medullary\\ nephrocalcinosis\ \(0\)\
\-\ the\\ primary\\ differential\\ covering\\ the\\ majority\\ of\\ cases\\:\ \(0\)\
\-\ 1\\.\\	hyperparathyroidism\ \(0\)\
\-\ 2\\.\\	renal\\ tubular\\ acidosis\ \(0\)\
\-\ 3\\.\\	medullary\\ sponge\\ kidney\ \(0\)\
\-\ an\\ exhaustive\\ differential\\ includes\\â\\€\\¦\\.\ \(0\)\
\-\ hypercalciuria\\:\\ hyperparathyroidism\ \(0\)\
\-\ \\	paraneoplastic\\ syndrome\\ of\\ lung\\ and\\ renal\\ primaries\ \(0\)\
\-\ \\	cushings\\ syndrome\ \(0\)\
\-\ \\	diabetes\\ insipidis\ \(0\)\
\-\ \\	hyper\\ or\\ hypothyroidism\ \(0\)\
\-\ alimentary\\:\\ mild\\-alkali\\ syndrome\ \(0\)\
\-\ \\	hypervitaminosis\\ d\ \(0\)\
\-\ \\	beryllium\\ poisoning\ \(0\)\
\-\ osseous\\:\\ osseous\\ mets\\,\\ multiple\\ myeloma\ \(0\)\
\-\ \\	porlonged\\ immobilization\ \(0\)\
\-\ \\	progessive\\ senile\\ osteoporosis\ \(0\)\
\-\ renal\\:\\	medullary\\ sponge\\ kidney\ \(0\)\
\-\ \\	renal\\ tubular\\ acidosis\ \(0\)\
\-\ \\	barter\\ syndrome\ \(0\)\
\-\ drugs\\:\\	furosemide\\ in\\ infants\ \(0\)\
\-\ \\	prolonged\\ acth\\ therapy\ \(0\)\
\-\ \\	excess\\ vitamin\\ e\\,\\ d\\ or\\ calcium\ \(0\)\
\-\ \\	nephrotoxic\\ drugs\\ such\\ as\\ amphotericin\\ b\ \(0\)\
\-\ miscellaneous\ \(1\)\
\-\ \\	sarcoidosis\ \(0\)\
\-\ \\	idiopathic\\ hypercalciuria\\ or\\ hypercalcemia\ \(0\)\
\-\ 35\\ year\\ old\\ white\\ male\\ with\\ flank\\ pain\\.\\ patient\\ has\\ history\\ of\\ frequent\\ stone\\ passage\\,\\ sometimes\\ as\\ frequently\\ as\\ every\\ other\\ day\ \(0\)\
\-\ with\\ treatment\\,\\ the\\ patient\\ noted\\ a\\ decrease\\ in\\ the\\ number\\ of\\ stones\\ he\\ would\\ pass\\,\\ from\\ 2\\-3\\ a\\ day\\,\\ down\\ to\\ 1\\ every\\ week\\ or\\ two\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ medullary\\:\\ 0\\.26058404780020733\ \(0\)\
\-\ acidosis\\:\\ 0\\.2511634511191441\ \(0\)\
\-\ renal\\:\\ 0\\.22935277174110008\ \(0\)\
\-\ hypercalciuria\\:\\ 0\\.20722593012595078\ \(0\)\
\-\ tubular\\:\\ 0\\.1919853064746383\ \(0\)\
\-\ nephrocalcinosis\\:\\ 0\\.17885310087028794\ \(0\)\
\-\ sponge\\:\\ 0\\.17885310087028794\ \(0\)\
\-\ syndrome\\:\\ 0\\.1776285500506322\ \(0\)\
\-\ drugs\\:\\ 0\\.14733233760851835\ \(0\)\
\-\ every\\:\\ 0\\.14269434933471983\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.14032952930301543\ \(0\)\
\-\ flank\\:\\ 0\\.12922024927012865\ \(0\)\
\-\ insipidis\\:\\ 0\\.11779937969080681\ \(0\)\
\-\ beryllium\\:\\ 0\\.11779937969080681\ \(0\)\
\-\ porlonged\\:\\ 0\\.11779937969080681\ \(0\)\
\-\ senile\\:\\ 0\\.11779937969080681\ \(0\)\
\-\ barter\\:\\ 0\\.11779937969080681\ \(0\)\
\-\ osseous\\:\\ 0\\.11758545761037664\ \(0\)\
\-\ exhaustive\\:\\ 0\\.11256359614817558\ \(0\)\
\-\ progessive\\:\\ 0\\.11256359614817558\ \(0\)\
\-\ alimentary\\:\\ 0\\.1088487486056066\ \(0\)\
\-\ nephrotoxic\\:\\ 0\\.10596728899230852\ \(0\)\
\-\ primaries\\:\\ 0\\.10361296506297539\ \(0\)\
\-\ cushings\\:\\ 0\\.10361296506297539\ \(0\)\
\-\ miscellaneous\\:\\ 0\\.10361296506297539\ \(0\)\
\-\ kidney\\:\\ 0\\.1034985725780898\ \(0\)\
\-\ or\\:\\ 0\\.10250088301937764\ \(0\)\
\-\ bicarbonate\\:\\ 0\\.10162241254344845\ \(0\)\
\-\ hypervitaminosis\\:\\ 0\\.09989811752040642\ \(0\)\
\-\ furosemide\\:\\ 0\\.09701665790710831\ \(0\)\
\-\ acth\\:\\ 0\\.09578591459310758\ \(0\)\
\-\ differential\\:\\ 0\\.09572221373549393\ \(0\)\
\-\ day\\:\\ 0\\.0938411124796155\ \(0\)\
\-\ amphotericin\\:\\ 0\\.09362874000590389\ \(0\)\
\-\ microhematuria\\:\\ 0\\.09267178145824824\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.09094748643520621\ \(0\)\
\-\ poisoning\\:\\ 0\\.09094748643520621\ \(0\)\
\-\ covering\\:\\ 0\\.090164638809511\ \(0\)\
\-\ potassium\\:\\ 0\\.08942655043514397\ \(0\)\
\-\ as\\:\\ 0\\.08877626519712335\ \(0\)\
\-\ hydration\\:\\ 0\\.08806602682190812\ \(0\)\
\-\ mixture\\:\\ 0\\.08743599791561701\ \(0\)\
\-\ of\\:\\ 0\\.08649035284496069\ \(0\)\
\-\ excess\\:\\ 0\\.0862612765162941\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.0862612765162941\ \(0\)\
\-\ sodium\\:\\ 0\\.08571170289257499\ \(0\)\
\-\ mild\\:\\ 0\\.08351223118359227\ \(0\)\
\-\ passage\\:\\ 0\\.0812140077243108\ \(0\)\
\-\ hyper\\:\\ 0\\.07977774764130147\ \(0\)\
\-\ constant\\:\\ 0\\.07944232537807247\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.07848536683041682\ \(0\)\
\-\ vitamin\\:\\ 0\\.07731064543109391\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.07676107180737479\ \(0\)\
\-\ infants\\:\\ 0\\.07676107180737479\ \(0\)\
\-\ myeloma\\:\\ 0\\.07649481431088986\ \(0\)\
\-\ pass\\:\\ 0\\.07597822418167957\ \(0\)\
\-\ mets\\:\\ 0\\.07572747783550349\ \(0\)\
\-\ creatinine\\:\\ 0\\.07500319280940908\ \(0\)\
\-\ immobilization\\:\\ 0\\.07188905967454974\ \(0\)\
\-\ prolonged\\:\\ 0\\.07134717466735992\ \(0\)\
\-\ remaining\\:\\ 0\\.07000435226468132\ \(0\)\
\-\ stones\\:\\ 0\\.06953473574521661\ \(0\)\
\-\ sometimes\\:\\ 0\\.06893402133750698\ \(0\)\
\-\ number\\:\\ 0\\.0678104407221746\ \(0\)\
\-\ frequent\\:\\ 0\\.06754418322568967\ \(0\)\
\-\ diabetes\\:\\ 0\\.0672833050382096\ \(0\)\
\-\ stone\\:\\ 0\\.0672833050382096\ \(0\)\
\-\ majority\\:\\ 0\\.06690161130619339\ \(0\)\
\-\ calcium\\:\\ 0\\.06653087681663938\ \(0\)\
\-\ decrease\\:\\ 0\\.06331274555391041\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.062396543582159715\ \(0\)\
\-\ idiopathic\\:\\ 0\\.062308399683058444\ \(0\)\
\-\ frequently\\:\\ 0\\.06066119761186262\ \(0\)\
\-\ down\\:\\ 0\\.059837478744128834\ \(0\)\
\-\ 35\\:\\ 0\\.059063168659954174\ \(0\)\
\-\ the\\:\\ 0\\.05879185719509172\ \(0\)\
\-\ with\\:\\ 0\\.05769468720678403\ \(0\)\
\-\ pain\\:\\ 0\\.05271696681264927\ \(0\)\
\-\ would\\:\\ 0\\.05214300676000566\ \(0\)\
\-\ labs\\:\\ 0\\.05103275916710658\ \(0\)\
\-\ cases\\:\\ 0\\.04954447307338797\ \(0\)\
\-\ week\\:\\ 0\\.04954447307338797\ \(0\)\
\-\ white\\:\\ 0\\.04859919524211399\ \(0\)\
\-\ patient\\:\\ 0\\.04791620870073641\ \(0\)\
\-\ such\\:\\ 0\\.04738227004722687\ \(0\)\
\-\ severe\\:\\ 0\\.04663036355374623\ \(0\)\
\-\ treated\\:\\ 0\\.045870554348220016\ \(0\)\
\-\ primary\\:\\ 0\\.04529333954859634\ \(0\)\
\-\ lung\\:\\ 0\\.04480861122977155\ \(0\)\
\-\ two\\:\\ 0\\.04374368760788701\ \(0\)\
\-\ he\\:\\ 0\\.04361912364121301\ \(0\)\
\-\ therapy\\:\\ 0\\.04232280802993851\ \(0\)\
\-\ bilateral\\:\\ 0\\.039587939486500405\ \(0\)\
\-\ noted\\:\\ 0\\.039054756960430335\ \(0\)\
\-\ other\\:\\ 0\\.03825314658896345\ \(0\)\
\-\ in\\:\\ 0\\.036648747172933524\ \(0\)\
\-\ multiple\\:\\ 0\\.03602901616924867\ \(0\)\
\-\ treatment\\:\\ 0\\.03508846554130945\ \(0\)\
\-\ has\\:\\ 0\\.0336460284521649\ \(0\)\
\-\ male\\:\\ 0\\.032796545059316486\ \(0\)\
\-\ and\\:\\ 0\\.03044213378946375\ \(0\)\
\-\ normal\\:\\ 0\\.03007514038364462\ \(0\)\
\-\ from\\:\\ 0\\.029254878444438352\ \(0\)\
\-\ an\\:\\ 0\\.02816757678137485\ \(0\)\
\-\ history\\:\\ 0\\.02814262405654857\ \(0\)\
\-\ year\\:\\ 0\\.022700755209690362\ \(0\)\
\-\ old\\:\\ 0\\.021800583062728755\ \(0\)\
\-\ to\\:\\ 0\\.018415012238566182\ \(0\)\
